Home
News
Create
Screeners
Insights
Alpa Laboratories
68.
91
+0.66
(+0.97%)
Market Cap
₹144.99 Cr
PE Ratio
9.65
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.97%
1M
+1.34%
6M
-7.35%
1Y
-33.03%
5Y
+35.52%
View Company Insights
Latest news about Alpa Laboratories
Alpa Laboratories Ltd accepts resignation of Company Secretary
4 days ago
Alpa Laboratories Ltd has accepted the resignation of Ms. Yashoda Patidar as Company Secretary and Compliance Officer, effective July 26, 2026. The resignation is due to personal reasons, as per the regulatory filing submitted to the exchanges.
Alpa Laboratories FY26 PAT falls 24% to ₹15.01 crore
May 30, 2026
Alpa Laboratories Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer
Apr 11, 2026
Alpa Laboratories Clarifies No Price Sensitive Information Following Stock Exchange Inquiry
Apr 10, 2026
Alpa Laboratories Reports Promoter Share Transfer Under SEBI SAST Regulations
Mar 09, 2026
More news about Alpa Laboratories
25
Feb 26
Alpa Laboratories Company Secretary Ms. Srashiti Chopra Resigns Due to Personal Reasons
Alpa Laboratories Limited announced the resignation of Company Secretary and Compliance Officer Ms. Srashiti Chopra, effective March 25, 2026. The resignation, submitted on February 25, 2026, was due to personal reasons. The company has notified both NSE and BSE in compliance with SEBI regulations, with Ms. Chopra committed to ensuring smooth transition of responsibilities during the notice period.
11
Feb 26
Alpa Laboratories Reports Q3FY26 Results with Revenue Growth of 13.5% YoY
Alpa Laboratories Limited reported Q3FY26 results with revenue growth of 13.5% to Rs 2,967.12 lacs, but net profit declined 78.9% to Rs 187.48 lacs. Nine-month revenue grew 2.6% to Rs 7,441.40 lacs while profit fell 36.5% to Rs 1,375.20 lacs. The pharmaceutical company operates in drugs and chemicals segment.
Alpa Laboratories
68.
91
+
0.
66
(+
0.
97
%)
1 Year Returns:
-33.03%
Industry Peers
Sun Pharmaceutical
1,921.40
(-
0.
73
%)
Divis Laboratories
6,938.50
(+
1.
50
%)
Torrent Pharmaceuticals
4,951.10
(+
1.
01
%)
Cipla
1,426.70
(-
0.
88
%)
Lupin
2,492.60
(-
0.
15
%)
Zydus Life Science
1,131.30
(-
1.
69
%)
Mankind Pharma
2,507.50
(-
0.
70
%)
Dr Reddys Laboratories
1,234.50
(-
0.
79
%)
Aurobindo Pharma
1,549.30
(-
0.
98
%)
Laurus Labs
1,558.60
(+
1.
35
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar